<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35211828</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-6903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurochemical research</Title>
          <ISOAbbreviation>Neurochem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of the Notch Signaling Pathway on Secondary Brain Changes Caused by Spinal Cord Injury in Mice.</ArticleTitle>
        <Pagination>
          <StartPage>1651</StartPage>
          <EndPage>1663</EndPage>
          <MedlinePgn>1651-1663</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-022-03558-4</ELocationID>
        <Abstract>
          <AbstractText>Spinal cord injury (SCI) can cause secondary brain changes, leading to hypomyelination in the dorsolateral prefrontal cortex (dlPFC). Some studies have shown that notch signaling pathway activation can regulate oligodendrocyte maturation and myelination. The aim of this study was to investigate whether inhibition of the Notch signaling pathway can alleviate hypomyelination in the dlPFC caused by SCI. Moreover, we further investigated whether the changes in myelination in the dlPFC are associated with neuropathic pain following SCI. We established a mouse model of SCI and observed the changes in mechanical and thermal hyperalgesia. Western blotting and immunofluorescence were used to analyze the changes in myelination in the dlPFC. The results indicated the existence of a relationship between activation of the Notch signaling pathway and hypomyelination in the dlPFC and confirmed the existence of a relationship between hypomyelination in the dlPFC and decreases in mechanical and thermal hyperalgesia thresholds. In conclusion, these results suggested that the Notch signaling pathway is activated after SCI, leading to hypomyelination in the dlPFC, and that DAPT can inhibit the Notch signaling pathway and improve mechanical and thermal hyperalgesia thresholds. Our findings provide a new target for the treatment of neuropathic pain caused by SCI.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chengcai</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Shaoxin</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Basic Medicine, Jiujiang University, Jiujiang, 332005, Jiangxi, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Wu</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Zhiping</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Shenke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Meihua</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, NO17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China. limeihua2000@sina.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurochem Res</MedlineTA>
        <NlmUniqueID>7613461</NlmUniqueID>
        <ISSNLinking>0364-3190</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006930" MajorTopicYN="N">Hyperalgesia</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009437" MajorTopicYN="Y">Neuralgia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013119" MajorTopicYN="Y">Spinal Cord Injuries</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dorsolateral prefrontal cortex</Keyword>
        <Keyword MajorTopicYN="N">Hypomyelination</Keyword>
        <Keyword MajorTopicYN="N">NG2 cell</Keyword>
        <Keyword MajorTopicYN="N">Notch signaling pathway</Keyword>
        <Keyword MajorTopicYN="N">Secondary brain change</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35211828</ArticleId>
        <ArticleId IdType="doi">10.1007/s11064-022-03558-4</ArticleId>
        <ArticleId IdType="pii">10.1007/s11064-022-03558-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nave KA, Werner HB (2014) Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30:503–533</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25288117</ArticleId>
            <ArticleId IdType="doi">10.1146/annurev-cellbio-100913-013101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffiths I, Klugmann M, Anderson T et al (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280(5369):1610–1613</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9616125</ArticleId>
            <ArticleId IdType="doi">10.1126/science.280.5369.1610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dang TC, Ishii Y, Nguyen V et al (2019) Powerful homeostatic control of oligodendroglial lineage by PDGFRalpha in adult brain. Cell Rep 27(4):1073–1089</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31018125</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.03.084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young KM, Psachoulia K, Tripathi RB et al (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77(5):873–885</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23473318</ArticleId>
            <ArticleId IdType="pmc">3842597</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2013.01.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang SH, Fukaya M, Yang JK et al (2010) NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68(4):668–681</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21092857</ArticleId>
            <ArticleId IdType="pmc">2989827</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2010.09.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valny M, Honsa P, Kriska J et al (2017) Multipotency and therapeutic potential of NG2 cells. Biochem Pharmacol 141:42–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28522408</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bcp.2017.05.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravanelli AM, Kearns CA, Powers RK et al (2018) Sequential specification of oligodendrocyte lineage cells by distinct levels of Hedgehog and Notch signaling. Dev Biol 444(2):93–106</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30347186</ArticleId>
            <ArticleId IdType="pmc">6263812</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ydbio.2018.10.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C, Xie Z, Xing Z et al (2021) The Notch signaling pathway regulates differentiation of NG2 cells into oligodendrocytes in demyelinating diseases. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-021-01089-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10571-021-01089-0</ArticleId>
            <ArticleId IdType="pubmed">34562223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Argaw AT, Gurfein BT et al (2009) Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 106(45):19162–19167</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19855010</ArticleId>
            <ArticleId IdType="pmc">2776461</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.0902834106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Sdrulla AD, Disibio G et al (1998) Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21(1):63–75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697852</ArticleId>
            <ArticleId IdType="doi">10.1016/S0896-6273(00)80515-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genoud S, Lappe-Siefke C, Goebbels S et al (2002) Notch1 control of oligodendrocyte differentiation in the spinal cord. J Cell Biol 158(4):709–718</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12186854</ArticleId>
            <ArticleId IdType="pmc">2174019</ArticleId>
            <ArticleId IdType="doi">10.1083/jcb.200202002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dovey HF, John V, Anderson JP et al (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76(1):173–181</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11145990</ArticleId>
            <ArticleId IdType="doi">10.1046/j.1471-4159.2001.00012.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evin G, Sernee MF, Masters CL (2006) Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer’s disease: prospects, limitations and strategies. CNS Drugs 20(5):351–372</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16696577</ArticleId>
            <ArticleId IdType="doi">10.2165/00023210-200620050-00002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geling A, Steiner H, Willem M et al (2002) A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 3(7):688–694</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12101103</ArticleId>
            <ArticleId IdType="pmc">1084181</ArticleId>
            <ArticleId IdType="doi">10.1093/embo-reports/kvf124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sueda R, Imayoshi I, Harima Y et al (2019) High Hes1 expression and resultant Ascl1 suppression regulate quiescent vs. active neural stem cells in the adult mouse brain. Genes Dev 33(9–10):511–523</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30862661</ArticleId>
            <ArticleId IdType="pmc">6499325</ArticleId>
            <ArticleId IdType="doi">10.1101/gad.323196.118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi M, Liu Z, Lv Y et al (2011) Forced notch signaling inhibits commissural axon outgrowth in the developing chick central nerve system. PLoS ONE 6(1):e14570</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21283742</ArticleId>
            <ArticleId IdType="pmc">3024975</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0014570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284(5415):770–776</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10221902</ArticleId>
            <ArticleId IdType="doi">10.1126/science.284.5415.770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hains BC, Waxman SG (2006) Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26(16):4308–4317</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16624951</ArticleId>
            <ArticleId IdType="pmc">6674010</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0003-06.2006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Cao T, Ritzel RM et al (2020) Dementia, depression, and associated brain inflammatory mechanisms after spinal cord injury. Cells 9(6):1420</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">7349379</ArticleId>
            <ArticleId IdType="doi">10.3390/cells9061420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon EJ, Kim YK, Shin HI et al (2013) Cortical and white matter alterations in patients with neuropathic pain after spinal cord injury. Brain Res 1540:64–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24125807</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainres.2013.10.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gustin SM, Wrigley PJ, Siddall PJ et al (2010) Brain anatomy changes associated with persistent neuropathic pain following spinal cord injury. Cereb Cortex 20(6):1409–1419</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19815621</ArticleId>
            <ArticleId IdType="doi">10.1093/cercor/bhp205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Apkarian VA, Hashmi JA, Baliki MN (2011) Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain 152(3 Suppl):S49–S64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21146929</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pain.2010.11.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Q, Yan W, Li X et al (2012) Activation of canonical notch signaling pathway is involved in the ischemic tolerance induced by sevoflurane preconditioning in mice. Anesthesiology 117(5):996–1005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22929735</ArticleId>
            <ArticleId IdType="doi">10.1097/ALN.0b013e31826cb469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Z, Huang S, Xie S et al (2021) Potential correlation between depression-like behavior and the mitogen-activated protein kinase pathway in the rat hippocampus following spinal cord injury. World Neurosurg 154:e29–e38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34271150</ArticleId>
            <ArticleId IdType="doi">10.1016/j.wneu.2021.06.093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang P, Chen X, Hu X et al (2020) Experimentally induced sepsis causes extensive hypomyelination in the prefrontal cortex and hippocampus in neonatal rats. Neuromolecular Med 22(3):420–436</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32638208</ArticleId>
            <ArticleId IdType="doi">10.1007/s12017-020-08602-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aparicio E, Mathieu P, Pereira LM et al (2013) The Notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination. J Neurochem 127(6):819–836</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24032544</ArticleId>
            <ArticleId IdType="doi">10.1111/jnc.12440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basso DM, Fisher LC, Anderson AJ et al (2006) Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23(5):635–659</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16689667</ArticleId>
            <ArticleId IdType="doi">10.1089/neu.2006.23.635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai T, Morishima K, Takagi-Niidome S et al (2019) Conformational dynamics of transmembrane domain 3 of presenilin 1 Is associated with the trimming activity of gamma-secretase. J Neurosci 39(43):8600–8610</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31527118</ArticleId>
            <ArticleId IdType="pmc">6807281</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0838-19.2019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian L, Guo R, Yue X et al (2012) Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats. Brain Res 1440:47–55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22284619</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainres.2011.12.059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pajoohesh-Ganji A, Burns MP, Pal-Ghosh S et al (2014) Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury. Brain Res 1560:73–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24630972</ArticleId>
            <ArticleId IdType="pmc">4129635</ArticleId>
            <ArticleId IdType="doi">10.1016/j.brainres.2014.02.049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi S, Sasaki T, Katayama T et al (2010) Temporal-spatial expression of presenilin 1 and the production of amyloid-beta after acute spinal cord injury in adult rat. Neurochem Int 56(3):387–393</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19932144</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuint.2009.11.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du M, Tan Y, Liu G et al (2017) Effects of the Notch signalling pathway on hyperoxia-induced immature brain damage in newborn mice. Neurosci Lett 653:220–227</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28583585</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neulet.2017.05.065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddall PJ, Mcclelland JM, Rutkowski SB et al (2003) A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 103(3):249–257</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12791431</ArticleId>
            <ArticleId IdType="doi">10.1016/S0304-3959(02)00452-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dimou L, Gallo V (2015) NG2-glia and their functions in the central nervous system. Glia 63(8):1429–1451</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26010717</ArticleId>
            <ArticleId IdType="pmc">4470768</ArticleId>
            <ArticleId IdType="doi">10.1002/glia.22859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belachew S, Chittajallu R, Aguirre AA et al (2003) Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 161(1):169–186</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12682089</ArticleId>
            <ArticleId IdType="pmc">2172886</ArticleId>
            <ArticleId IdType="doi">10.1083/jcb.200210110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehebauer M, Hayward P, Arias AM (2006) Notch, a universal arbiter of cell fate decisions. Science 314(5804):1414–1415</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17138893</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1134042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond TR, Gadea A, Dupree J et al (2014) Astrocyte-derived endothelin-1 inhibits remyelination through notch activation. Neuron 81(3):588–602</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24507193</ArticleId>
            <ArticleId IdType="pmc">3935216</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2013.11.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jurynczyk M, Selmaj K (2010) Notch: a new player in MS mechanisms. J Neuroimmunol 218(1–2):3–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19748685</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2009.08.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui XY, Hu QD, Tekaya M et al (2004) NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol Chem 279(24):25858–25865</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15082708</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M313505200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang P, Zhou Q, Lin Q et al (2020) Complement C3a induces axonal hypomyelination in the periventricular white matter through activation of WNT/beta-catenin signal pathway in septic neonatal rats experimentally induced by lipopolysaccharide. Brain Pathol 30(3):495–514</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31622511</ArticleId>
            <ArticleId IdType="doi">10.1111/bpa.12798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu QD, Ang BT, Karsak M et al (2003) F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115(2):163–175</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14567914</ArticleId>
            <ArticleId IdType="doi">10.1016/S0092-8674(03)00810-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan H, Shen F, Li L et al (2021) Activation of the Notch signaling pathway in the anterior cingulate cortex is involved in the pathological process of neuropathic pain. Pain 162(1):263–274</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32701650</ArticleId>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000002014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen XH, Johnson VE, Uryu K et al (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19(2):214–223</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18492093</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1750-3639.2008.00176.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilton BJ, Moulson AJ, Tetzlaff W (2017) Neuroprotection and secondary damage following spinal cord injury: concepts and methods. Neurosci Lett 652:3–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27939975</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neulet.2016.12.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Zhao Z, Sabirzhanov B et al (2014) Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J Neurosci 34(33):10989–11006</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25122899</ArticleId>
            <ArticleId IdType="pmc">4131014</ArticleId>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5110-13.2014</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
